BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37155190)

  • 1. Significant Incidental Findings in the National Lung Screening Trial.
    Gareen IF; Gutman R; Sicks J; Tailor TD; Hoffman RM; Trivedi AN; Flores E; Underwood E; Cochancela J; Chiles C
    JAMA Intern Med; 2023 Jul; 183(7):677-684. PubMed ID: 37155190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings.
    Gareen IF; Black WC; Tosteson TD; Wang Q; Sicks JD; Tosteson ANA
    Med Care; 2018 May; 56(5):403-409. PubMed ID: 29613874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidental Findings on Low-Dose CT Scan Lung Cancer Screenings and Deaths From Respiratory Diseases.
    Pinsky PF; Lynch DA; Gierada DS
    Chest; 2022 Apr; 161(4):1092-1100. PubMed ID: 34838524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial.
    Gareen IF; Duan F; Greco EM; Snyder BS; Boiselle PM; Park ER; Fryback D; Gatsonis C
    Cancer; 2014 Nov; 120(21):3401-9. PubMed ID: 25065710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
    JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.
    Pinsky PF; Gierada DS; Black W; Munden R; Nath H; Aberle D; Kazerooni E
    Ann Intern Med; 2015 Apr; 162(7):485-91. PubMed ID: 25664444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overdiagnosis in low-dose computed tomography screening for lung cancer.
    Patz EF; Pinsky P; Gatsonis C; Sicks JD; Kramer BS; Tammemägi MC; Chiles C; Black WC; Aberle DR;
    JAMA Intern Med; 2014 Feb; 174(2):269-74. PubMed ID: 24322569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality.
    Prosper AE; Inoue K; Brown K; Bui AAT; Aberle D; Hsu W
    JAMA Netw Open; 2021 Aug; 4(8):e2119629. PubMed ID: 34427681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of Incidental Findings and Subsequent Evaluation in Low-Dose Computed Tomographic Scans for Lung Cancer Screening.
    Morgan L; Choi H; Reid M; Khawaja A; Mazzone PJ
    Ann Am Thorac Soc; 2017 Sep; 14(9):1450-1456. PubMed ID: 28421812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
    Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
    Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals.
    Landy R; Wang VL; Baldwin DR; Pinsky PF; Cheung LC; Castle PE; Skarzynski M; Robbins HA; Katki HA
    JAMA Netw Open; 2023 Mar; 6(3):e233273. PubMed ID: 36929398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
    Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
    Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary Results of Lung Cancer Screening in a Socioeconomically Disadvantaged Population.
    Guichet PL; Liu BY; Desai B; Surani Z; Cen SY; Lee C
    AJR Am J Roentgenol; 2018 Mar; 210(3):489-496. PubMed ID: 29166147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of radiographic emphysema in assessing lung cancer risk.
    Yong PC; Sigel K; de-Torres JP; Mhango G; Kale M; Kong CY; Zulueta JJ; Wilson D; Brown SW; Slatore C; Wisnivesky J
    Thorax; 2019 Sep; 74(9):858-864. PubMed ID: 30723183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
    Patz EF; Greco E; Gatsonis C; Pinsky P; Kramer BS; Aberle DR
    Lancet Oncol; 2016 May; 17(5):590-9. PubMed ID: 27009070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute.
    Gohagan J; Marcus P; Fagerstrom R; Pinsky P; Kramer B; Prorok P;
    Chest; 2004 Jul; 126(1):114-21. PubMed ID: 15249451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort.
    Ruparel M; Quaife SL; Dickson JL; Horst C; Tisi S; Hall H; Taylor MN; Ahmed A; Shaw PJ; Burke S; Soo MJ; Nair A; Devaraj A; Sennett K; Hurst JR; Duffy SW; Navani N; Bhowmik A; Baldwin DR; Janes SM
    Ann Am Thorac Soc; 2020 Jul; 17(7):869-878. PubMed ID: 32164439
    [No Abstract]   [Full Text] [Related]  

  • 19. Variation in Reporting of Incidental Findings on Initial Lung Cancer Screening and Associations With Clinician Assessment.
    Melzer AC; Atoma B; Fabbrini AE; Campbell M; Clothier BA; Fu SS
    J Am Coll Radiol; 2024 Jan; 21(1):118-127. PubMed ID: 37516160
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.